Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Net Income (2016 - 2025)

Historic Net Income for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $19.1 million.

  • Veracyte's Net Income rose 2633.35% to $19.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.3 million, marking a year-over-year increase of 42692.18%. This contributed to the annual value of $24.1 million for FY2024, which is 13244.18% up from last year.
  • According to the latest figures from Q3 2025, Veracyte's Net Income is $19.1 million, which was up 2633.35% from -$980000.0 recorded in Q2 2025.
  • Veracyte's 5-year Net Income high stood at $19.1 million for Q3 2025, and its period low was -$41.9 million during Q1 2021.
  • Moreover, its 5-year median value for Net Income was -$8.4 million (2023), whereas its average is -$7.2 million.
  • Its Net Income has fluctuated over the past 5 years, first plummeted by 63033.04% in 2023, then soared by 47703.86% in 2025.
  • Veracyte's Net Income (Quarter) stood at -$10.5 million in 2021, then skyrocketed by 63.16% to -$3.9 million in 2022, then tumbled by 630.33% to -$28.3 million in 2023, then soared by 118.16% to $5.1 million in 2024, then skyrocketed by 272.53% to $19.1 million in 2025.
  • Its last three reported values are $19.1 million in Q3 2025, -$980000.0 for Q2 2025, and $7.0 million during Q1 2025.